NCT04068948View on ClinicalTrials.gov

Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2023

Conditions
Dental Caries in ChildrenPediatric Dental SedationMeperidineHydroxyzineMidazolam
Interventions
DRUG

Meperidine

This intervention assesses a child's behavioral outcome for dental procedural sedation in combination with midazolam and hydroxyzine. Children participating in the study will randomly be assigned to receive either a drug regimen of midazolam+hydroxyzine, or midazolam+hydroxyzine+meperidine.

DRUG

Hydroxyzine

This intervention is given to children for a sedative effect. Children participating in the study will randomly be assigned to receive either a drug regimen of midazolam+hydroxyzine, or midazolam+hydroxyzine+meperidine.

DRUG

Midazolam

This intervention is given to children for a sedative effect. Children participating in the study will randomly be assigned to receive either a drug regimen of midazolam+hydroxyzine, or midazolam+hydroxyzine+meperidine.

Trial Locations (1)

98115

University of Washington Center for Pediatric Dentistry, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT04068948 - Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years | Biotech Hunter | Biotech Hunter